Relationship Between Serum Apolipoprotein Levels and Weight Loss in Patients Undergoing Sleeve Gastrectomy for Morbid Obesity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study looks at whether a specific protein in the blood, called apolipoprotein, can predict how much weight a person might lose after sleeve gastrectomy, a surgery for people with severe obesity. We want to find a specific level of this protein that shows which patients are most likely to lose weight successfully after surgery. By identifying this level, we hope to guide doctors in deciding who should have the surgery and who might do better with non-surgical weight loss methods.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

the Change in Carotid Intima-media Thickness After Laparoscopic Sleeve Gastrectomy

NCT06882616

Weight Loss Reduce the Risk of Cardiac Disease Carotis Intima-media Thickness

COMPLETED NA

Istmin Levels in Laparoscopik Sleeve Gastrectomy

NCT07335549

Obesity & Overweight Sleeve Gastrectomy Adipokines

COMPLETED

Effect of Clips Versus Omentopexy on Postoperative Bleeding

NCT06211699

Bleeding Postoperative Complications Postoperative Nausea and Vomiting

COMPLETED NA

Correlation of Preoperative Gastric Residual Volume With Body Mass Index and Aspiration Risk in Laparoscopic Bariatric Surgery

NCT07032207

Obesity Gastric Ultrasound Gastric Residual Volume +1 more

RECRUITING

8-Year Outcomes After Sleeve Gastrectomy

NCT07348822

Sleeve Gastrectomy Obesity & Overweight

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The subject of our research is whether serum apolipoprotein levels can be a predictive value for weight loss in patients who will undergo sleeve gastrectomy due to morbid obesity. Our aim is to determine a cut-off value for patients who benefit most from bariatric surgery based on preoperative serum apolipoprotein levels. By including this value among the surgical indications, we plan to direct patients less likely to benefit from surgery to conservative approaches.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morbid Obesity Requiring Bariatric Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sleeve Gastrectomy Patients

Patients who meet inclusion criteria for the study undergoing sleeve gastrectomy

Laparoscopic Sleeve Gastrectomy

Intervention Type PROCEDURE

Laparoscopic Sleeve Gastrectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic Sleeve Gastrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 to 75
* International Classification of Diseases (ICD) code E66 diagnosis (obesity)
* Patients who have given consent for sleeve gastrectomy
* Patients who are suitable for general anesthesia